Key market opportunities in the AI clinical trial protocol feasibility tool sector include rising demand for personalized and ...

The FDA has put a clinical hold on a Tenaya Therapeutics gene therapy study | The FDA has put a clinical hold on a Tenaya ...

WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the launch of its next-generation Data & Insights Solutions. Guided by the ...

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...

Raising key scientific and clinical concerns, the Subject Experts Committee (SEC) has declined to recommend the Phase III ...

Partnership integrates customized kitting, just-in-time operations, and nationwide distribution to accelerate decentralized and hybrid trials NEW BRUNSWICK, NEW JERSEY / ACCESS Newswire / November 14, ...

Get key insights from PDS Biotech’s Q3 2025 earnings call, including regulatory updates for PDS0101 in HPV16+ cancer and financial highlights.

Tenaya Therapeutics said on Friday the U.S. Food and Drug Administration has placed a clinical hold on its trial of an ...

BEVERLY, MA – November 10, 2025 – PRESSADVANTAGE – Trial management has become one of the most decisive factors in determining whether diagnostic and medtech innovations make it to market successfully ...

Get Q3 2025 earnings insights on DiaMedica Therapeutics (DMAC): clinical progress, DM199 trial updates, financials, and strategic outlook.

Roughly 70 to 80% of ovarian cancer cases are diagnosed at an advanced stage,1 where treatment options are limited and ...